Clinical Study Site

Florence 50134

1 studies enrolling now · 3 studies all time

What they study most

Fabry Disease, Metastatic Colorectal Cancer (CRC), Paroxysmal Nocturnal Hemoglobinuria (PNH)

Studies at this site

• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer — Recruiting now
• Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab — Completed
• Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease — Completed